Two years ago, Pfizer announced it had partnered with biotech company Celldex to develop a brain cancer vaccine. At the time, many people thought the move heralded the beginning of pharmaceutical companies developing personalized treatments for patients, says Robert Langreth on Forbes' Treatments blog. But now Pfizer has dissolved the partnership, leaving Celldex to try and develop the drug on its own.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.